Chong, P. S., Fung, M. L., Wong, K. H., & Lim, L. W. (2020). Therapeutic potential of Hericium erinaceus for depressive disorder. International journal of molecular sciences, 21(1), 163.
Hu, J. H., Li, I. C., Lin, T. W., Chen, W. P., Lee, L. Y., Chen, C. C., & Kuo, C. F. (2019). Absolute Bioavailability, Tissue Distribution, and Excretion of Erinacine S in Hericium erinaceus Mycelia. Molecules (Basel, Switzerland), 24(8), 1624. https://doi.org/10.3390/molecules24081624
Inanaga, K., Yoshida, M., Tomita, O., & Uchimura, N. (2015). Treatment of Mild Neurocognitive Disorder with Compounds from Hericium Erinaceum. International Medical Journal, 22(3).
Kawagishi, H., Ando, M., Sakamoto, H., Yoshida, S., Ojima, F., Ishiguro, Y.,Furukawa, S. (1991). Hericenones C, D and E, stimulators of nerve growth factor (NGF)-synthesis, from the mushroom Hericium erinaceum. Tetrahedron Letters, 32(35), 4561–4564. doi:10.1016/0040-4039(91)80039-9
Kawagishi, H., Zhuang, C., & Shnidman, E. (2004). The anti-dementia effect of Lion’s Mane mushroom (Hericium erinaceum) and its clinical application. Townsend letter for doctors and Patients, (249), 54-57.
Kim, Y. O., Lee, S. W., & Kim, J. S. (2014). A comprehensive review of the therapeutic effects of Hericium erinaceus in neurodegenerative disease. Journal of Mushroom, 12(2), 77-81.
Lai, P. L., Naidu, M., Sabaratnam, V., Wong, K. H., David, R. P., Kuppusamy, U. R., et al. (2013). Neurotrophic properties of the Lion’s mane medicinal mushroom, Hericium erinaceus (higher basidiomycetes) from Malaysia. Int. J. Med. Mushrooms 15, 539–554. doi: 10.1615/intjmedmushr.v15.i6.30
Li, I. C., Lee, L. Y., Tzeng, T. T., Chen, W. P., Chen, Y. P., Shiao, Y. J., & Chen, C. C. (2018). Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines. Behavioural neurology, 2018, 5802634. https://doi.org/10.1155/2018/5802634
Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009 Mar;23(3):367-72. doi: 10.1002/ptr.2634. PMID: 18844328.
Mori, K., Inatomi, S., Ouchi, K., Azumi, Y., & Tuchida, T. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: A double‐blind placebo‐controlled clinical trial. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 23(3), 367-372.
Mori, K., Obara, Y., Hirota, M., Azumi, Y., Kinugasa, S., Inatomi, S., & Nakahata, N. (2008). Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biological and Pharmaceutical Bulletin, 31(9), 1727-1732.
Phan, C.-W., Lee, G.-S., Hong, S.-L., Wong, Y.-T., Brkljača, R., Urban, S., … Sabaratnam, V. (2014). Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropical conditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways. Food Funct., 5(12), 3160–3169. doi:10.1039/c4fo00452c
Rupcic, Z., Rascher, M., Kanaki, S., Köster, R. W., Stadler, M., & Wittstein, K. (2018). Two new cyathane diterpenoids from mycelial cultures of the medicinal mushroom Hericium erinaceus and the rare species, Hericium flagellum. International journal of molecular sciences, 19(3), 740.
Shimbo, M., Kawagishi, H., and Yokogoshi, H. (2005). Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats. Nutr. Res. 25, 617–623.
Vigna, L., Morelli, F., Agnelli, G. M., Napolitano, F., Ratto, D., Occhinegro, A., … & Rossi, P. (2019). Hericium erinaceus improves mood and sleep disorders in patients affected by overweight or obesity: could circulating pro-BDNF and BDNF be potential biomarkers?. Evidence-Based Complementary and Alternative Medicine, 2019.